1-8 of 8
Joel W. Neal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: a Lung-MAP Study

Available to Purchase
Philip C. Mack, Mary W. Redman, Hanna Tukachinsky, David E. Kozono, Katherine Minichiello, Konstantin H. Dragnev, Khaled A. Tolba, Joel W. Neal, Russell W. Madison, Saiama N. Waqar, Charu Aggarwal, Fred R. Hirsch, Jyoti D. Patel, Roy S. Herbst, Anne C. Chiang, Karen L. Reckamp, Karen Kelly, Hossein Borghaei, Jhanelle E. Gray, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2025)
https://doi.org/10.1158/1078-0432.CCR-24-3658
Published: 04 June 2025
View articletitled, Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: a Lung-MAP Study
Open the PDF for Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: a Lung-MAP Study in another window
Includes: Supplementary data
Journal Articles

Abstract PO-069: Circulating tumor DNA kinetics to identify genomic predictors of rapid response to chemoradiation in non-small cell lung cancer

Free
Everett J. Moding, Yufei Liu, Angela B. Hui, Jianzhong He, Yawei Qiao, Ting Xu, Luyang Yao, Saumil Gandhi, Zhongxing Liao, Millie Das, Kavitha J. Ramchandran, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee, Billy W. Loo, Steven H. Lin, Ash A. Alizadeh, Maximilian Diehn
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-069.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-069
Published: 15 April 2021
View articletitled, Abstract PO-069: Circulating tumor DNA kinetics to identify genomic predictors of rapid response to chemoradiation in non-small cell lung cancer
Journal Articles

Abstract PO-059: Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer

Free
Michael S. Binkley, Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Nabet, Diego Almanza, Christopher Yoo, David M. Kurtz, Susie Grant Owen, Leah M. Backhus, Mark F. Berry, Joseph B. Shrager, Kavitha J. Ramchandran, Sukhmani K. Padda, Millie Das, Joel W. Neal, Heather A. Wakelee, Ash A. Alizadeh, Billy W. Loo, Maximilian Diehn
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-059.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-059
Published: 15 April 2021
View articletitled, Abstract PO-059: Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer
Journal Articles

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Available to Purchase
Matthew D. Hellmann, Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark P.S. Dunphy, Jacob J. Chabon, Chih Long Liu, Angela B. Hui, Kathryn C. Arbour, Jia Luo, Isabel R. Preeshagul, Everett J. Moding, Diego Almanza, Rene F. Bonilla, Jennifer L. Sauter, Hyejin Choi, Megan Tenet, Mohsen Abu-Akeel, Andrew J. Plodkowski, Rocio Perez Johnston, Christopher H. Yoo, Ryan B. Ko, Henning Stehr, Linda Gojenola, Heather A. Wakelee, Sukhmani K. Padda, Joel W. Neal, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Taha Merghoub, Bob T. Li, Ash A. Alizadeh, Maximilian Diehn
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2849–2858.
https://doi.org/10.1158/1078-0432.CCR-19-3418
Published: 15 June 2020
View articletitled, Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
Open the PDF for Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC in another window
Includes: Supplementary data
Journal Articles

Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer

Available to Purchase
Youngtae Jeong, Jessica A. Hellyer, Henning Stehr, Ngoc T. Hoang, Xiaomin Niu, Millie Das, Sukhmani K. Padda, Kavitha Ramchandran, Joel W. Neal, Heather Wakelee, Maximilian Diehn
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (1): 274–281.
https://doi.org/10.1158/1078-0432.CCR-19-1237
Published: 03 January 2020
View articletitled, Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer
Open the PDF for Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B30: Three-dimensional organoid model for acquired drug resistance in non-small cell lung cancer

Free
Navika D. Shukla, Ameen A. Salahudeen, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee, Calvin J. Kuo
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17_Supplement): B30.
https://doi.org/10.1158/1557-3265.AACRIASLC18-B30
Published: 01 September 2018
View articletitled, Abstract B30: Three-dimensional organoid model for acquired drug resistance in non-small cell lung cancer
Journal Articles

Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

Free
Leora Horn, Jeffrey R. Infante, Karen L. Reckamp, George R. Blumenschein, Ticiana A. Leal, Saiama N. Waqar, Barbara J. Gitlitz, Rachel E. Sanborn, Jennifer G. Whisenant, Liping Du, Joel W. Neal, Jon P. Gockerman, Gary Dukart, Kimberly Harrow, Chris Liang, James J. Gibbons, Allison Holzhausen, Christine M. Lovly, Heather A. Wakelee
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (12): 2771–2779.
https://doi.org/10.1158/1078-0432.CCR-17-2398
Published: 14 June 2018
View articletitled, Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
Open the PDF for Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study in another window
Includes: Supplementary data
Journal Articles

One Allele's Loss Is Another's Gain: Alterations of NKX2–8 in Non–Small Cell Lung Cancer

Free
Joel W. Neal, Alice T. Shaw
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 638–639.
https://doi.org/10.1158/1078-0432.CCR-10-3081
Published: 15 February 2011
View articletitled, One Allele's Loss Is Another's Gain: Alterations of NKX2–8 in Non–Small Cell Lung Cancer
Open the PDF for One Allele's Loss Is Another's Gain: Alterations of NKX2–8 in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data